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Spleen tyrosine kinase Syk and its substrate SLP65 (also
called BLNK) are proximal signal transducer elements of
the B-cell antigen receptor (BCR). Yet, our understanding
of signal initiation and processing is limited owing to
the incomplete list of SLP65 interaction partners and
our ignorance of their association kinetics. We have now
determined and quantiﬁed the in vivo interactomes of
SLP65 in resting and stimulated B cells by mass spectro-
metry. SLP65 orchestrated a complex signal network of about
30 proteins that was predominantly based on dynamic inter-
actions. However, a stimulation-independent and constant
association of SLP65 with the Cbl-interacting protein of
85kDa (CIN85) was requisite for SLP65 phosphorylation
and its inducible plasma membrane translocation. In the
absence of a steady SLP65/CIN85 complex, BCR-induced
Ca
2þ and NF-jB responses were abrogated. Finally, live
cell imaging and co-immunoprecipitation experiments
further conﬁrmed that both SLP65 and CIN85 are key
components of the BCR-associated primary transducer
module required for the onset and progression phases of
BCR signal transduction.
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Introduction
Two biochemical principles characterize initiation and pro-
cessing of antigen-induced signalling in lymphocytes. First,
antigen receptor-proximal effector proteins assemble into
multimeric complexes in a rapid and transient manner.
Second, the formation of these early signalosomes is accom-
panied by subcellular relocation of one or more of the
molecules involved, most prominently from the cytosol into
signalling-competent membrane microdomains. The acti-
vated B-cell antigen receptor (BCR) recruits the tandemly
arranged Src homology (SH) 2 domains of spleen tyrosine
kinase Syk (Zioncheck et al, 1988; Hutchcroft et al, 1991,
1992) to a phosphorylated immunoreceptor tyrosine-based
activation motif (ITAM) in Iga (CD79a) and Igb (CD79b) (for
review, see Engels et al, 2008 and Geahlen, 2009). Syk and its
phospho-ITAM-mediated activation provide a common trig-
ger for many B-cell signalling cascades including Ca
2þ
mobilization (Engelke et al, 2007; Scharenberg et al, 2007),
induction of MAP kinase pathways (Hashimoto et al, 1998;
Jiang et al, 1998) and nuclear translocation of transcription-
ally active NF-kB dimers (Schulze-Luehrmann and Ghosh,
2006).
The proximal and dominant Syk substrate in BCR-stimu-
lated cells is the SH2 domain-containing leukocyte adaptor
protein of 65kDa (SLP65; Wienands et al, 1998) alternatively
named BLNK (Fu et al, 1998) or BASH (Goitsuka et al, 1998).
Nine tyrosine residues become rapidly phosphorylated upon
BCR activation (Oellerich et al, 2009). Together with the
complex involvement of 29 serine and 6 threonine residues
intricate phosphorylation patterns are generated which en-
able SLP65 to act upstream for triggering the signal as well as
downstream during selective processing of the BCR signal
(Oellerich et al, 2009). Hence, SLP65 is a genuine signal
integrator which is as mandatory as Syk for normal B
lymphopoiesis and humoral immunity (Jumaa et al, 1999;
Minegishi et al, 1999; Pappu et al, 1999; Hayashi et al, 2000;
Xu et al, 2000).
Fulﬁlling the signal integration function requires differen-
tial networking of SLP65 with numerous interaction partners.
This has been worked out to a great detail for the SLP65-
mediated nucleation of the Ca
2þ initiation complex. Three
distinct phosphotyrosine residues in SLP65 serve as docking
sites for the SH2 domains of phospholipase C-g2 (PLC-g2)
and Bruton’s tyrosine kinase (Btk) (Hashimoto et al, 1999;
Ishiai et al, 1999; Su et al, 1999; Chiu et al, 2002). Within this
trimolecular arrangement Btk phosphorylates and thereby
activates PLC-g2. It remained unclear how the Ca
2þ initiation
complex anchors inducibly to the plasma membrane to
provide PLC-g2 with access to its substrate phosphatidylino-
sitol-4,5 bisphosphate, which upon hydrolysis yields the
second messengers inositol-trisphosphate and diacylglycerol.
Mutational analysis revealed that membrane recruitment of
SLP65 requires both the N-terminal basic region and the
C-terminal SH2 domain (Kohler et al, 2005; Abudula et al,
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36202007). A ligand for the basic effector region has not yet been
identiﬁed. Binding of the SH2 domain to a non-ITAM phos-
photyrosine in Iga places SLP65 in close vicinity to ITAM-
bound Syk and facilitates SLP65 phosphorylation (Engels
et al, 2001; Kabak et al, 2002), which in turn augments
B-cell responses to T cell-independent antigens (Patterson
et al, 2006). Nonetheless, Syk can phosphorylate SLP65
even in the absence of the non-ITAM tyrosine. It is unknown
at what subcellular location this crucial step of signal initia-
tion occurs and how the enzyme–substrate interaction is
accomplished. However, genetic reconstitution experiments
from our group provided evidence that the initiation of
signalling requires protein complexes that are already formed
before BCR stimulation (Wienands et al, 1996). Collectively,
these examples suggest the existence of so far unidentiﬁed
effector proteins of BCR signal initiation and processing.
To ﬁll the gaps in our understanding of proximal BCR
signalling, we have now determined the interactome of SLP65
in resting and stimulated B cells by quantitative mass spectro-
metry. Additional monitoring of the association kinetics
revealed a class of steady ligands whose preformed associa-
tion to SLP65 in resting cells remained unaltered upon BCR
activation. One of those permanent SLP65 companions was
the Cbl-interacting protein of 85kDa (CIN85) also named
Ruk or SH3KBP1. Steady complex formation between CIN85
and SLP65 orchestrated Syk-mediated phosphorylation and
membrane translocation of SLP65 and globally affected the
composition of the SLP65 interactome. Mutational analysis
showed that CIN85 is a novel key component of the BCR-
associated transducer complex.
Results
SILAC-based interactome analysis provides a library for
the SLP65 signalling network
To search for missing links of the primary BCR transducer
complex, we determined the interactome of SLP65 using
stable isotope labelling with amino acids in cell culture
(SILAC) in combination with mass spectrometric analysis of
afﬁnity-puriﬁed protein complexes (Ong et al, 2002;
Neumann et al, 2009; Selbach et al, 2009). Therefore,
slp65
 /  DT40 B cells were reconstituted with an SLP65
variant harbouring an N-terminal One Strep tag that was
expressed in almost identical amounts compared with en-
dogenous SLP65 in wild-type cells (see Figure 1A). Cells
expressing tagged SLP65 were cultured in SILAC medium
containing lysine and arginine amino acids that have incor-
porated ‘heavy’ isotopes of carbon and nitrogen (
13C and
15N). As negative control, DT40 cells expressing non-tagged
SLP65 were cultured in the presence of lysines and arginines
encompassing carbon
12C and nitrogen
14N, so-called ‘light’
isotopes. Proteins from the two culture conditions contained
either ‘heavy’ or ‘light’ lysines and arginines (Supplementary
Figure S1). Accordingly, the two culture conditions confer
distinct molecular masses on the cellular proteins synthe-
sized; and thus, proteins derived from ‘heavily’ and ‘lightly’
labelled cells can be distinguished by mass spectrometry. For
elucidation of the SLP65 interactome in the absence of BCR
stimulation, the differentially labelled cells were lysed with-
out further treatment. Proteins were afﬁnity puriﬁed with a
Strep-tactin column, pooled at a 1:1 ratio and hydrolysed with
endoproteinase trypsin. Peptides were identiﬁed by liquid
chromatography (LC)-coupled tandem mass spectrometry
(MS/MS) and allocated to the corresponding protein by
database search. Relative quantiﬁcation of all sequenced
peptides was performed using MaxQuant software (Cox
et al, 2009) and is shown in Supplementary Table 1. An at
least ﬁve-fold enrichment of heavy versus light peptides was
considered to mark those proteins that were speciﬁcally co-
puriﬁed with One Strep-tagged SLP65 from resting cells. To
identify inducible SLP65 interactors, we compared afﬁnity-
puriﬁed SLP65 complexes derived from ‘lightly labelled’
resting cells with those from ‘heavily labelled’ cells stimu-
lated through their BCR for 2, 5, 10 or 20min.
In addition to previously reported SLP65 binders, a large
number of unknown ligands were identiﬁed. Altogether, 29
proteins constituted the SLP65 interactome (Table I). Only a
few ligand interactions existed in resting B cells, most notably
to UNC119b implicated in the regulation of protein tyrosine
kinase activity (Cen et al, 2003; Gorska et al, 2004) and to the
SH3 domain-containing adaptor proteins Grb2, CIN85 and
CD2-associated protein (CD2AP). CIN85 and CD2AP share a
similar domain architecture encompassing three N-terminal
SH3 domains followed by a proline-rich region and a
C-terminal coiled-coil domain (Dustin et al, 1998; Take
et al, 2000; Dikic, 2002). Since both adaptor proteins associ-
ate ﬁrmly and constitutively with actin-capping proteins Z
(CapZ; Hutchings et al, 2003), the detection of CapZ isoforms
as part of the SLP65 interactome in resting as well as
stimulated B cells might be due to indirect co-puriﬁcation
of these cytoskeleton regulators. However, SLP65 appeared to
possess several links to the cytoskeleton as also talin, proﬁlin
and Nck all implicated in actin ﬁlament dynamics (Buday
et al, 2002; Le Clainche and Carlier, 2008) were identiﬁed as
inducible ligands. Consistent with the role of SLP65 as up-
stream regulator of B-cell signalling cascades (Engelke et al,
2007), the inducible interactome accommodated positive-
and negative-regulatory components of BCR-induced Ca
2þ
mobilization and MAP kinase activation. Finally, the C-type
lectin 17A (CLEC17A) may contribute to SLP65 membrane
recruitment as its cytoplasmic tail harbours binding sites
for SH2 and SH3 domains. A glycan-binding protein with
similar overall structure is also found in mammals and called
prolectin (Graham et al, 2009).
The association kinetics of individual SLP65 interactors
deﬁnes distinct ligand classes
Our description of the SLP65 interactome provided informa-
tion about the ligands’ identities and whether the correspond-
ing complexes were dependent on BCR activation. However,
this type of analysis does not take account of the dynamic
nature of signal transduction processes as it lacks information
about association kinetics. Thus, we quantiﬁed individual
SLP65 ligands at different time points of BCR stimulation
using a combined triple SILAC/MS approach with B cells that
all expressed One Strep-tagged SLP65. Note that tagged SLP65
was expressed by the reconstituted cells in similar amounts
compared with endogenous SLP65 in wild-type cells
(Figure 1A). Cells were metabolically labelled in ‘light’
(Lysþ0/Argþ0), ‘medium’ (Lysþ4/Argþ6) or ‘heavy’
(Lysþ8/Argþ10) SILAC medium (see Materials and meth-
ods for details) and either left untreated or stimulated for 2
and 5, or 10 and 20min, respectively (see Figure 1A).
Afﬁnity-puriﬁed SLP65 complexes were mixed at a 1:1:1
The BCR transducer module
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&2011 European Molecular Biology Organization The EMBO Journal VOL 30 | NO 17 | 2011 3621Figure 1 Association kinetics of SLP65 ligands. (A, top part) Immunoblot analysis with anti-SLP65 or anti-actin antibodies (upper and lower
panels, respectively) of SLP65-negative DT40 B-cell mutants (lane 1), wild-type DT40 cells (wt, lane 2) and mutants cells that were
reconstituted with One Strep-tagged SLP65 (lane 3) and provide the basis for all mass spectrometric ligand identiﬁcation and quantiﬁcation
analysis. (A, bottom part) Schematic representation of a two-fold triple SILAC approach for relative quantiﬁcation of individual SLP65 ligands
under different stimulation conditions. DT40 B cells expressing One Strep-tagged SLP65 were cultured in SILAC medium containing the
differentially labelled amino acids Lysþ0/Argþ0o rL y s þ4/Argþ6o rL y s þ8/Argþ10. In a ﬁrst approach, cells were left untreated or
stimulated through their BCR for 2 or 20min, respectively. In a complementary experiment to obtain continuous kinetics, cells were left
untreated or BCR stimulated for 5 or 10min. From each approach, the afﬁnity-puriﬁed SLP65 signalosomes were mixed at a 1:1:1 ratio. Ligands
were identiﬁed and relatively quantiﬁed by LC-MS/MS using MaxQuant software. Note that not all interaction kinetics of SLP65 ligands could
be measured owing to the increased sample complexity in our combined triple SILAC approach that reveals certain technical limitations of the
MS instrument to detect low-abundant peptide pairs of ligands that only transiently or weakly interact with SLP65, for example, Btk and Syk.
(B–D) The amounts of individual SLP65 ligands measured under distinct stimulation conditions were normalized according to the association
quantity observed in resting cells (determined in both approaches). Subsequently, the mean values of the three independent doublet
experiments were combined to a single time course of ﬁve different stimulation conditions as both sets contained quantitative interaction
values from resting B cells which allowed for normalization of the data facilitated by the MaxQuant software. Based on this analysis, SLP65
ligands were classiﬁed as being early and transient (B), late and sustained (C) or steady (D). For detailed data sets and statistics, see
Supplementary Table 2. (E) Human Ramos B cells left untreated (lanes 1 and 2) or BCR stimulated for 2, 5, 10 or 20min (lanes 3–6) were lysed
and subjected to immunoprecipitations with anti-SLP65 antibodies (lanes 2–6) or isotype-matched control antibodies (lane 1, ctrl). Obtained
proteins were analysed by immunoblotting with antibodies directed against CD2AP, Dok-3, CapZ, Sek1/MAPKK4, PLC-g2 and Grb2 (upper to
lower panel, respectively). (F) Lysates of BCR-negative J558L B cells were subjected to immunoprecipitations using antibodies to SLP65 (lane
2) or CD2AP (lane 4) or isotype-matched control antibodies (lanes 1 and 3). Obtained proteins were analysed by immunoblotting with
antibodies recognizing CIN85 or SLP65 (lanes 1–2, upper and lower left panels, respectively), or SLP65 and CD2AP (lanes 3–4, upper and lower
right panels, respectively). Relative molecular masses of marker proteins are indicated on the left in kDa.
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as quantiﬁed as described above.
The relative association kinetics uncovered the dynamic
nature of SLP65 complex formations and revealed three
ligand classes. The class of early but transient interactors
(Figure 1B) contained regulatory components of the Ca
2þ
ﬂux pathway as well as Nck, Grb2 and CLEC17A. A second
class of ligands characterized by a late and sustained associa-
tion (Figure 1C) was represented by CapZ isoforms and the
serine/threonine protein phosphatase 2 (PP2). Finally, we
detected steady ligands whose association to SLP65 was
almost unaffected by BCR engagement in that it was already
‘preformed’ before BCR activation and remained unchanged
thereafter (Figure 1D). This class of constant SLP65 inter-
actors contained CD2AP and CIN85. No BCR-induced loss of
binding was observed. Co-immunoprecipitation experiments
using human and murine B cells (Figure 1E and F) corrobo-
rated our proteomic results obtained in the avian system.
Moreover, the constitutive association between SLP65 and
CIN85/CD2AP adaptors in BCR-negative J558L B cells
(Figure 1F, left and right panels, respectively) showed that
formation of these steady complexes was also independent of
so-called ‘tonic’ BCR signalling in the absence of ligand
(Monroe, 2006). In summary, quantitative monitoring of the
association kinetics distinguished various classes of SLP65
ligands. Early interaction partners became rapidly engaged
upon BCR stimulation and may generally reﬂect master
regulators of BCR-proximal signalling pathways. Late inter-
action partners may be involved in signal processing.
The function of the preformed and constant interactors was
less obvious as they may act upstream or downstream of
SLP65 or both.
Steady ligands CIN85 and CD2AP bind atypical
SH3-binding motifs of SLP65
A stimulation-independent assembly of BCR effector proteins
into preformed signalling complexes has been suggested as
requisite for antigen-induced tyrosine phosphorylation of
Table I The interactome of SLP65
Ligand IPI number Function References
In resting B cells
Grb2 00576615 Adaptor protein This study (Fu et al, 1998; Wienands et al, 1998)
CIN85 00601097 Adaptor protein This study (Watanabe et al, 2000)
CD2AP 00583892 Adaptor protein This study
CapZ-a1 00583945 Cytoskeleton regulator This study
CapZ-a2 00582081 Cytoskeleton regulator This study
CapZ-b1/2 00591422 Cytoskeleton regulator This study
Similar to Unc119b 00584927 Src kinase regulator This study
Hsp70 00582091 Chaperone This study
Hsp105 00590633 Chaperone This study
Ig heavy chain-binding protein 00590375 Chaperone This study
In activated B cells
Iga (CD79A) 00591677 BCR component This study (Engels et al, 2001)
CLEC17A 00599471 Transmembrane lectin This study
Grb2 00576615 Adaptor protein This study (Fu et al, 1998; Wienands et al, 1998)
CIN85 00601097 Adaptor protein This study (Watanabe et al, 2000)
CD2AP 00583892 Adaptor protein This study
Dok-3 00845156 Adaptor protein This study
Nck2 00599713 Cytoskeleton adaptor This study (Fu et al, 1998)
CapZ-a1 00583945 Cytoskeleton regulator This study
CapZ-a2 00582081 Cytoskeleton regulator This study
CapZ-b1/2 00591422 Cytoskeleton regulator This study
Talin 00586709 Cytoskeleton regulator This study
Proﬁlin 00600305 Cytoskeleton regulator This study
Similar to Unc119b 00584927 Src kinase regulator This study
Lyn 00579414 Protein tyrosine kinase This study
Syk 00603504 Protein tyrosine kinase This study (Abudula et al, 2007; Kulathu et al, 2008)
Btk
a 00595247 Protein tyrosine kinase This study (Hashimoto et al, 1999; Su et al, 1999)
PLC-g2 00587921 Phospholipase This study (Fu et al, 1998)
VAV3 00578220 GTP exchange factor This study (Fu et al, 1998; Wienands et al, 1998)
Sek1/MAPKK4 00594829 MAP kinase This study
Protein phosphatase 2 00651162 Ser/Thr phosphatase This study
AIF (programmed cell death 8) 00601063 Apoptosis This study
Ig heavy chain-binding protein 00590375 Chaperone This study
Hsp70 00582091 Chaperone This study
Hsp105 00590633 Chaperone This study
WD repeat domain 81 00602009 Unknown This study
CCH domain-containing 4 00574478 Unknown This study
Hypothetical 00602230 Unknown This study
Hypothetical 00597453 Unknown This study
Hypothetical 00813608 Unknown This study
Two independent SILAC-based LC-MS/MS analyses were performed for resting DT40 B cells and cells stimulated through their BCR for 2, 5, 10
and 20min. Detailed statistics including total number of all identiﬁed and quantiﬁed peptides as well as their signiﬁcance and variability scores
are shown in Supplementary Table 1. Listed proteins showed an at least ﬁve-fold enrichment of heavy versus light peptides.
aThe known ligand Btk co-migrated with the dominating protein band of Strep-tagged SLP65 and was thus less well detectable in this set-up but
identiﬁed in a separate approach with GFP-tagged SLP65.
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1996, 1998). The identity and architecture of the preformed
signalosomes remained unclear ever since. The steady SLP65
ligands CIN85 and/or CD2AP were candidate components as
their multifunctionality has been implicated in several as-
pects of cell surface receptor biology (Dikic, 2002). We
wanted to test this possibility by mutational analysis and
mapped the interaction sites between SLP65 and CIN85/
CD2AP. SLP65 accommodates three evolutionary conserved
proline/arginine-based docking motifs (Figure 2A) that
match the previously reported atypical recognition consensus
PXXXPR of the three SH3 domains of CIN85 and CD2AP
(Kowanetz et al, 2003; Kurakin et al, 2003). Exchange of the
critical arginine residue to alanine (R-to-A) within the three
binding motifs abolished co-immunoprecipitation of SLP65
with both CIN85 and CD2AP from resting and BCR-activated
B cells (Figure 2B, left panel). Consistently, glutathione-S
transferase (GST) fusion proteins encompassing the three
SH3 domains of CD2AP or CIN85 afﬁnity-puriﬁed wild-type
SLP65 but not the triple R-to-A variant (Figure 2B, middle
panel and data not shown). Hence, atypical proline/arginine
motifs in SLP65 and the SH3 domains of CIN85/CD2AP
were necessary and sufﬁcient for steady complex formation
in vivo. Binding studies with recombinantly expressed SLP65
and GST fusion proteins encompassing the triple SH3 do-
mains of CIN85 conﬁrmed that the interaction is direct
(Figure 2B, right panel). Furthermore, the interaction is
highly selective as shown by SILAC-based mass spectrometric
determination of all putative PXXXPR ligands that exist in B
cells. Figure 2C shows that biotinylated peptides encompass-
ing the central proline/arginine motif of SLP65 almost exclu-
sively puriﬁed CIN85 and CD2AP along with their intimate
CapZ binding partners from B-cell lysates cultured in heavy
SILAC medium. B cells that were cultured in light SILAC
medium and subjected to afﬁnity puriﬁcation with a mutant
form of the peptide served as control and for normalization of
the binding scores. The only SH3 domain-containing protein
that in addition to CIN85 and CD2AP showed a signiﬁcant yet
four-fold weaker binding score was Grb2. Hence, dependent
on protein availability these sites may to some extent also
bind Grb2. Collectively, these experiments demonstrated that
assembly of the preformed SLP65 signalosome was based on
the exquisite binding speciﬁcity of the atypical PXXXPR
motifs which selectively recruited CIN85 and CD2AP.
Steady ligands control the functionality and
composition of the SLP65 interactome
The functional role of the preformed SLP65 signalosome was
assessed ﬁrst in primary mouse B cells from which the
endogenous proteins can be efﬁciently co-immunoprecipi-
tated (Figure 3A, inlay of upper panel). Next, we retrovirally
transduced splenic B cells from SLP65-deﬁcient mice (Jumaa
et al, 1999) to express citrine-tagged wild-type or triple R-to-A
mutant SLP65. Equal expression of SLP65 proteins was
conﬁrmed by ﬂow cytometric monitoring of the citrine fusion
partner (data not shown). As shown in Figure 3A (upper
panel), expression of wild-type but not mutant SLP65 recon-
stituted the BCR-induced Ca
2þ response. Note that the weak
Ca
2þ ﬂux proﬁle elicited in B cells expressing the R-to-A
mutant overlapped with that of SLP65-negative cells. Hence,
ablation of CIN85/CD2AP binding to SLP65 generated a loss-
of-function mutant in splenic B cells. Similarly, BCR-induced
Ca
2þ mobilization was blunted in DT40 B-cell transfectants
expressing the triple R-to-A variant (Figure 3A, lower panel,
purple and red curves). Single R-to-A exchanges in individual
proline/arginine motifs (blue, brown and green curves)
revealed a dominating role for the two C-terminal docking
sites, whose combined inactivation was sufﬁcient to pheno-
copy the Ca
2þ blockade of the triple mutant (light blue and
purple curves) and to abolish binding to the SH3 domains of
CIN85 and CD2AP (data not shown). To deﬁne the Ca
2þ
block, we analysed BCR-induced tyrosine phosphorylation of
wild-type and mutant SLP65 as well as activation of PLC-g2.
Loss of CIN85/CD2AP almost abrogated SLP65 phosphoryla-
tion (Figure 3B, left panels) and strongly compromised PLC-g2
activation as shown by anti-phosphotyrosine immunoblot
analysis of anti-PLC-g2 precipitates (Figure 3B, right panels).
Moreover, R-to-A mutant SLP65 was unable to promote
activation of the NF-kB pathway (Figure 3C). By contrast,
Lyn and Syk were equally well phosphorylated on their
activatory tyrosines in the presence of wild-type and mutant
SLP65 (Figure 3D, left and right panels, respectively). Taken
together, the preformed complex between CIN85/CD2AP
adaptors and SLP65 is dispensable for linking the BCR to
the activation of Lyn and Syk, but required for SLP65
phosphorylation and subsequent activation of Ca
2þ and
NF-kB responses.
The functional deﬁcits of R-to-A mutant SLP65 suggested a
more general role of the steady complex for the SLP65-
controlled signalling network. To test this possibility in a
comprehensive and quantitative manner, we modiﬁed our
SILAC-based ligand screening and compared the stimulation-
dependent interactome of wild-type SLP65 with that of the
triple R-to-A variant by ‘reverse proteomics’. DT40 B cells
expressing wild-type or mutant SLP65 were cultured in ‘light’
(Lysþ0/Argþ0) or ‘heavy’ (Lysþ8/Argþ10) SILAC med-
ium, respectively. Following BCR stimulation of the cells for
2min, the interactomes of wild-type and mutant SLP65 were
afﬁnity puriﬁed and identiﬁed as described above. The
amount of a given ligand puriﬁed with the R-to-A variant
was normalized to that obtained with wild-type SLP65
(Figure 3E). Consistent with our previous results, no binding
between mutant SLP65 and CIN85 or CD2AP was detected.
Similarly, the association to the CIN85/CD2AP-associated
CapZ isoforms was almost lost. Inactivation of the CIN85/
CD2AP binding sites in SLP65 also abrogated some but not all
inducible interactions, for example to Nck or the Ca
2þ
regulators PLC-g2 and VAV3. By contrast, the R-to-A ex-
changes only moderately affected networking of SLP65 with
other ligands such as CLEC17A, Dok-3 and proﬁlin. Hence,
loss of CIN85/CD2AP binding caused qualitative and quanti-
tative changes in the composition of the SLP65 interactome.
The data conﬁrmed a more general upstream regulatory
function of the preformed SLP65 signalosome and showed
that our approach of ‘reverse proteomics’ elucidates putative
effectors of a given protein–protein interaction in an unbiased
manner.
SLP65 and CIN85 constitute a proximal BCR transducer
module
The phosphorylation defect of the R-to-A variant demon-
strated a disturbed kinase-substrate reaction between Syk
and SLP65 that was likely to arise from local sequestration
of the two proteins. In fact, it is unknown at what subcellular
The BCR transducer module
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The EMBO Journal VOL 30 | NO 17 | 2011 &2011 European Molecular Biology Organization 3624Figure 2 Atypical SH3 binding motifs of SLP65 selectively and directly recruit the steady ligands CIN85 and CD2AP. (A) Domain architecture
of SLP65 and amino-acid sequences of the three atypical proline/arginine motifs (indicated by a–c) in human and murine SLP65. (B, top part)
Domain architecture of CIN85/CD2AP adaptors. (B, bottom parts) SLP65-deﬁcient DT40 B cells (slp65
 / ) were reconstituted with green
ﬂuorescence protein (GFP)-tagged forms of either human wild-type SLP65 or a mutant version harbouring R-to-A amino-acid exchanges in all
three atypical SH3 domain-binding motifs of the PXXXPR type (R49, 248 and 313A). Cells were left untreated (00) or BCR stimulated for the
indicated times in minutes (left and middle panels), and subjected either to immunoprecipitation (IP) with anti-GFP antibodies followed by
immunoblot analysis of obtained proteins with antibodies recognizing CIN85, CD2AP or SLP65 (left panel, upper, middle and lower blots,
respectively), or to afﬁnity puriﬁcations using glutathione-S transferase (GST) fusion proteins encompassing the three SH3 domains of CD2AP
(GST–CD2AP(SH3)3), or GSTalone as negative control, followed by immunoblotting with antibodies recognizing SLP65 or GST (middle panel,
upper and lower blots, respectively). Direct protein–protein interactions were tested in vitro by mixing recombinantly expressed HIS-tagged
SLP65 with immobilized GST–CIN85(SH3)3, or immobilized GST alone as control, followed by immunoblot analysis of bound proteins with
anti-SLP65 or anti-GSTantibodies (right panel, upper and lower blots, respectively). Relative molecular masses of marker proteins are indicated
on the left in kDa. (C) DT40 B cells were metabolically labelled in heavy (Lysþ8/Argþ10) SILAC medium and lysates were incubated with
biotinylated peptides encompassing the central PXXXPR motif of human SLP65 (KSPPPAAPSPLPRAGKKPT). For control, DT40 B cells were
cultured in light (Lysþ0/Argþ0) SILAC medium and their lysates were incubated with biotinylated peptides, in which prolines at positions 10
and 13 were exchanged for alanine (KSPPPAAPSALPAAGKKPT). Puriﬁed proteins were mixed at a 1:1 ratio, digested with trypsin and
identiﬁed by quantitative LC-MS/MS analysis using MaxQuant software. All identiﬁed proteins are plotted according to their ‘heavy’ versus
‘light’ ratio of enrichment (H/L) on logarithmic scales. Proteins with H/L ratio 41 are indicated, that is, CD2AP, CIN85, CapZ-a1, -a2-, -b1 and
Grb2. Complete list of proteins and statistics is listed in Supplementary Table 3.
The BCR transducer module
T Oellerich et al
&2011 European Molecular Biology Organization The EMBO Journal VOL 30 | NO 17 | 2011 3625Figure 3 Loss of steady ligands abrogates SLP65 signalling functions. (A) Splenic B cells from slp65
 /  mice and SLP65-negative DT40 B cells
(top and bottom panels, respectively) were reconstituted with wild type or indicated mutant forms of GFP-tagged human SLP65, loaded with
the ratiometric Ca
2þ chelator INDO-1-AM and subjected to BCR-induced Ca
2þ ﬂux analysis by ﬂow cytometry. Inlay of top panel, lysates of
primary B cells that were left untreated (lane 2) or BCR stimulated for 2 or 5min (lanes 3 and 4, respectively) were subjected to
immunoprecipitation (IP) with anti-SLP65 antibodies (lanes 2–4) or irrelevant control antibodies, followed by immunoblot analysis of
obtained proteins with antibodies recognizing CIN85 or SLP65 (upper and lower blots, respectively). Relative molecular mass of marker protein
is indicated on the left in kDa. (B–D) DT40 B cells expressing GFP-tagged wild type or triple R-to-A mutant SLP65 were left untreated or BCR
stimulated for indicated times. Proteins obtained by anti-GFP or anti-PLC-g2 immunoprecipitations were analysed by anti-phosphotyrosine
immunoblotting (B, upper left and right panels). Equal loading was conﬁrmed by separate immunoblotting with antibodies recognizing SLP65
and PLC-g2 (lower left and right panels, respectively). Cleared cellular lysates were analysed by immunoblotting with phosphosite-speciﬁc
antibodies against phosphoserine of IkB-a, or the activatory phosphotyrosines of Lyn or Syk (C, D, upper left and right panels, respectively),
and anti-actin, anti-Lyn and anti-Syk antibodies as loading controls (C, D, lower left and right panels, respectively). Relative molecular masses
of marker proteins are indicated on the left in kDa. (E) Bar diagram representing the quantitative changes in binding of individual ligands to the
triple R-to-A mutant of SLP65 compared with wild-type SLP65 (‘Reverse Proteome Analysis’). DT40 B cells expressing One Strep-tagged
versions of wild-type or R-to-A mutant SLP65 were metabolically labelled in ‘light’ (Lysþ0/Argþ0) or ‘heavy’ (Lysþ8/Argþ10) SILAC
medium, respectively. Following BCR stimulation of the cells for 2min, the interactomes of wild-type and mutant SLP65 were afﬁnity puriﬁed
and identiﬁed by quantitative LC-MS/MS analysis as described in Figure 1A. The amount of a ligand associated with wild-type SLP65 was set as 1.
The relative increase or decrease in binding of ligands to mutant SLP65 is expressed as mean values of the fold change measured for the
corresponding ratios of heavy versus light signal peaks in three independent experiments. Error bars represent standard deviations. For complete
data set, see Supplementary Table 4.
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this aspect, we monitored the distribution of citrine-tagged
SLP65 versions in primary mouse B cells and DT40 B cells by
confocal laser scanning microscopy (Figure 4A and B, respec-
tively). In both types of B cells, wild-type SLP65 quantita-
tively translocated from the cytosol to the plasma membrane
in response to BCR activation (upper and lower panels, ﬁrst
row images). The R-to-A mutant was unable to relocate
(upper and lower panels, second row images) even upon
sustained B-cell stimulation (data not shown). This result
indicated an active role for CIN85 or CD2AP in providing
SLP65 with access to the plasma membrane where it meets
Syk. In support of this conclusion, a substantial amount of
the cellular pools of CIN85 and CD2AP localized to the
plasma membrane in resting B cells which increased upon
BCR ligation (Figure 4C). In case of CIN85, deletion of the
three SH3 domains trapped the molecule in the cytosol
(Figure 4D), while membrane recruitment of CD2AP was
largely independent of the SH3 domains (lower panel, second
row). Hence, wild-type CIN85 and CD2AP were both perma-
nent membrane residents but possess different anchoring
modes. This prompted us to visualize the exact localization
of SLP65, CIN85 and CD2AP to the plasma membrane with
improved effective resolution using total internal reﬂection
Figure 4 Steady ligands control inducible membrane translocation of SLP65. Confocal laser scanning microscopy of splenic B cells from
slp65
 /  mice (A) and SLP65-negative DT40 cells (B) expressing citrine-tagged versions of wild-type or R-to-A mutant human SLP65 (upper
and lower images, respectively), and of DT40 B cells expressing citrine-tagged versions of wild-type human CIN85 or human CD2AP (C), or
SH3 deletion mutants of CIN85 (CIN85DSH3, amino acids 329–665) or CD2AP (CD2APDSH3, amino acids 330–639) (D) in the absence (left
images) or presence (right images) of BCR ligation for the indicated times. Images of three independent experiments with DT40 B cells (B–D)
were analysed with ImageJ to determine signal intensities in the cytosol and at the plasma membrane of at least 50 cells for each time point.
Plotted values represent relative plasma membrane localization of the respective molecule calculated by the ratios of mean signal intensities in
the cytosol to those at the plasma membrane, which were normalized to the ratios of cytosolic versus membrane-bound proteins in
unstimulated cells. Error bars represent the 95% conﬁdence interval. Despite the representative images obtained from primary B-cell
transductants (A), a statistic quantiﬁcation was not possible because the number of cells expressing citrine-tagged SLP65 was too low for two
reasons. First, slp65
 /  mutant mice possess only few mature splenic B cells as a result of severely compromised B-cell development (Jumaa
et al, 1999). Second, the efﬁciency of retroviral transduction experiments is generally weak and further reduces the number of cells, which are
available for the microscopic analysis.
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trine-tagged versions of either of the three proteins were
settled on planar lipid bilayers loaded with RFP-labelled
anti-IgM antibodies. Previously, it was shown that B cells
on contact with anti-IgM-containing planar lipid bilayers
undergo a rapid spreading and a more prolonged contraction
response, resulting in the gathering of antigen in a central
cluster for internalization (Fleire et al, 2006). Concomitant
with spreading, numerous BCR-antigen microclusters are
formed that recruit cytoplasmic signalling molecules amplify-
ing the response and propagating B-cell spreading (Depoil
et al, 2008; Weber et al, 2008). As shown in Figure 5A and
Supplementary Movie 1, SLP65 colocalized to BCR micro-
clusters during spreading, and remained localized to the
central microcluster on completion of contraction. This is
consistent with SH2-mediated binding of SLP65 to the non-
ITAM phosphotyrosine in Iga (Engels et al, 2001; Kabak et al,
2002) and the requirement of SLP65 for the recruitment and
retention of PLC-g2 at the BCR microcluster (Weber et al,
2008). Likewise, CIN85 colocalized to BCR microclusters
following contact of the cells with anti-IgM-loaded lipid
bilayers (Figure 5B; Supplementary Movie 2). Interestingly,
Figure 5 CIN85 colocalizes to BCR microclusters. DT40 B cell expressing GFP-tagged versions of SLP65 (A), CIN85 (B, C) or CD2AP (D) was
settled on planar lipid bilayers containing B100 molecules of RFP-labelled anti-IgM antibodies per mm
2 and analysed by TIRF microscopy.
Data were acquired for 12min at one frame every 3s (see Supplementary Movies 1–4). (E) DT40 B cells expressing citrine-tagged versions of
CD2AP or CIN85 were left untreated or stimulated through their BCR for the indicated times and anti-IgM immunoprecipitates were subjected
to immunoblot analysis with antibodies to GFP, Syk and IgM (lanes 2–10, upper, middle and lower panels, respectively). Protein A/G agarose
beads served as control (ctrl, lane 1).
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as the distribution of CIN85 was not altered in B cells lacking
SLP65 (Figure 5C; Supplementary Movie 3). Very few CD2AP
molecules translocated into BCR microclusters (Figure 5D;
Supplementary Movie 4). Hence, CIN85 rather than CD2AP
may provide BCR-proximal transducer functions. Direct bio-
chemical evidence for this conclusion was provided by robust
co-immunoprecipitation of CIN85 with the activated BCR
(Figure 5E, lanes 6–10). Aweak interaction was also observed
between CD2AP and the BCR in resting cells (lanes 1–5).
CIN85 is the functionally dominant SLP65 ligand but can
be partially replaced by CD2AP
To further decipher distinct versus redundant roles of CIN85
and CD2AP for SLP65 signalling, we generated cd2ap
 / 
DT40 B cells by gene targeting and used RNA interference
to ‘knock down’ CIN85 expression in wild-type as well as
cd2ap
 /  mutant B cells. Figure 6A shows that lack of CD2AP
expression (left panel) had no inﬂuence on the magnitude or
duration of BCR-induced Ca
2þ mobilization (right panel). In
contrast, shRNA-mediated reduction of CIN85 expression
caused a moderate but signiﬁcant inhibition of Ca
2þ ﬂuxing
(Figure 6B, left and right panels). When CD2AP deﬁciency
was combined with reduced CIN85 expression the Ca
2þ
signal was strikingly diminished (Figure 6C, left and right
panels). These results further demonstrated that CD2AP and
CIN85 are no equal clients of SLP65. In the presence of
CIN85, CD2AP seems to be dispensable for SLP65-controlled
Ca
2þ ﬂux. However, CD2AP can partially compensate for
reduced CIN85 levels in shRNA-treated DT40 B cells as only a
combined deﬁcit in the expression of both, CIN85 and CD2AP,
had a major impact on the Ca
2þ response. The residual Ca
2þ
signalling in the latter situation can be explained by the fact
that RNA interference did not completely abolish CIN85
expression. It also remains possible that in the artiﬁcial
situation when CD2AP and CIN85 are not at all or only
weakly available other SLP65 ligands, for example, Grb2
(see above) may occupy the atypical SH3 domain-docking
Figure 6 CD2AP compensates for reduced expression of CIN85. (A) CD2AP-deﬁcient DT40 B cells were retrovirally transduced with a vector
encoding citrine-tagged avian CD2AP or an empty control vector, and subjected to immunoblot analysis of lysates with antibodies to either
CD2AP or actin (left, upper and lower panels, respectively), or to ratiometric analysis of Ca
2þ mobilization induced with 0.02mg/ml mouse
anti-IgM antibodies (right). (B, C) DT40 wild-type cells (B) or CD2AP-deﬁcient mutants (C) were retrovirally transduced to express shRNA
against CIN85 (shCIN) or control shRNA (mock). Cells were subjected to immunoblotting of lysates with antibodies recognizing CIN85, CD2AP
or actin (left, upper, middle and lower panels, respectively), or to ratiometric Ca
2þ analysis (right) as described in (A). Relative molecular
masses of marker proteins are indicated on the left in kDa.
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phosphorylated by Syk and is to some extent functional.
However, our genetic approach to generate mutant B cells
with modulated expression of CIN85 and/or CD2AP conﬁrmed
the important yet distinct roles of steady SLP65 ligands as
integral components of the BCR transducer complex.
CIN85 binding provides a subcellular localization signal
Binding of CIN85 to SLP65 can provide two principal func-
tions. First, constitutive occupancy of the atypical SH3
domain-binding motifs acts as a structural determinant that
holds SLP65 in a conformation which is accessible for Syk
phosphorylation. Second, the C-terminal part of CIN85 pro-
vides a targeting signal that directs SLP65 into the proximity
of the BCR and Syk. To directly test the second possibility, we
engineered the three CIN85 binding sites of SLP65 into the
T-cell adaptor SLP76 which lacks such motifs and whose
inability to functionally substitute SLP65 in B cells has been
explained by its mislocation and insufﬁcient interaction to
B-lymphoid effector proteins of the Ca
2þ mobilization pathway
(Ishiai et al, 2000; Wong et al, 2000). The sequence alignment
in Figure 7A illustrates the amino-acid changes introduced
into SLP76 at the three proline-rich motifs that correspond to
the CIN85/CD2AP binding sites in SLP65. A GFP-tagged
version of the engineered SLP76 variant (termed SLP76*)
was expressed in SLP65-deﬁcient B cells and tested for its
capability to communicate with the BCR signalling machinery.
Similar to SLP65 but in contrast to wild-type SLP76, SLP76*
associated constantly with CIN85 and became efﬁciently
tyrosine phosphorylated although with a delayed kinetic
(Figure 7B, left and right panels, respectively). Importantly,
SLP76*-expressing B cells mounted a robust Ca
2þ response
(Figure 7D). Inducible translocation into plasma membrane
speckles was observed for SLP76* but not for wild-type
SLP76 (Figure 7E). In summary, when equipped with the
CIN85 binding sites of SLP65, the T-cell adaptor SLP76
complemented SLP65 deﬁciency of B cells. This provides
direct evidence that CIN85 regulates the subcellular localiza-
tion of SLP adaptors in addition to a possible impact of CIN85
binding on the conformation of SLP65.
Discussion
It is well documented that a concerted action of Syk and
SLP65 initiates BCR signal transduction. Phospho-ITAMs in
the Igab heterodimer provide a physical link between the
activated BCR and Syk, and simultaneously enhance the
catalytic activity of Syk by allosteric regulation (Engels
et al, 2008). By contrast, the interaction mode between Syk
and SLP65 was unclear as the subcellular targeting mechan-
isms of SLP65 remained enigmatic. In the present report, we
have elucidated the SLP65 interactome and monitored the
association kinetics by relative quantiﬁcation of individual
complex formations for various stimulation periods. This
allowed for the classiﬁcation of SLP65 ligands into three
different groups, that is, early and transient interactors, late
Figure 7 T-cell SLP76 functions in B cells when equipped with CIN85 binding sites. (A) Amino-acid sequence alignment of corresponding SH3
domain-binding sites in human SLP65, SLP76 and SLP76*. Conserved proline and arginine residues are in black bold letters. The atypical
proline/arginine motifs are boxed. Genetically engineered amino-acid exchanges are marked in bold red. (B, C) SLP65-negative DT40 B cells
were reconstituted with GFP-tagged versions of wild-type SLP65, wild-type SLP76 or variant SLP76 accommodating three CIN85 binding sites
shown in (A). Cells were left untreated (00) or BCR stimulated for the indicated times in minutes (10 and 50) and SLP adaptors were
immunoprecipitated with anti-GFPantibodies. Obtained proteins were analysed by immunoblotting with antibodies to CIN85 (B, upper panel),
GFP (B, C, lower panels) or phosphotyrosine (C, upper panel). Relative molecular masses of marker proteins are indicated on the left in kDa.
(D, E) Cells described in (A) were subjected to BCR-induced Ca
2þ ﬂux analysis by ﬂow cytometry using INDO-1-AM (D) and confocal laser
scanning microscopy in the absence and presence of BCR stimulation for 3min to visualize subcellular localization of SLP adaptors (E).
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tinuously associate with SLP65 at a constant level. Members
of the ﬁrst two groups mainly contained master regulators of
BCR-proximal signalling pathways and response modulators
involved in signal integration and processing. The function of
the steady binding partners was less obvious, but their
stimulation-independent and non-dynamic association to
SLP65 was consistent with the functional properties of a
preformed BCR transducer complex that was predicted
based on genetic evidence and explained the efﬁcient cou-
pling of BCR-proximal effector molecules (Wienands et al,
1996). Indeed, steady complex formation of SLP65 with
CIN85 and/or CD2AP constitutes a functional unit as demon-
strated by proteomic and biochemical studies followed by the
mutational analyses in cultured and primary B cells, and
ﬁnally confocal and TIRF microscopy. The pivotal role of the
SLP65/CIN85 signalling module for humoral immunity is
demonstrated by almost abrogated T-independent type II
antibody responses in mutant mice with B cell-speciﬁc abla-
tion of CIN85 expression (Kometani and Kurosaki, 2011). In
direct accordance with our data, CIN85-deﬁcient B cells failed
to activate the NF-kB pathway in response to BCR ligation,
while the response to other stimuli such as anti-CD40, BAFF
or Il-4 was normal. These data further support the role of
CIN85 as a positive and speciﬁc signal effector of the BCR.
Our mass spectrometric elucidation of the SLP65 interac-
tome circumvented common disadvantages associated with
conventional approaches to characterize protein complexes,
for example, weak signal-to-noise ratios, loss of binding
partners owing to antibody-mediated complex disruption
and in vitro enrichment of false positive candidates. The
SLP65 interactors listed in Table I showed an at least ﬁve-
fold enrichment of heavily versus lightly labelled peptides.
This threshold is rather high compared with other SILAC-
based studies, where the signiﬁcance for ligand identiﬁcation
was deﬁned by an enrichment factor of 2.5 or 3 (Ong et al,
2002; Selbach et al, 2009). Thus, our collection unambigu-
ously represents in vivo ligands but some additional inter-
actors may be veriﬁed by future experiments. Nonetheless,
the large number of 29 identiﬁed ligands strongly suggests
the existence of distinct subcellular pools of SLP65, which
individually participate in the assembly of structurally and
functionally diverse complexes. This conclusion is further
supported by the highly complex and dynamic usage of 440
phosphoacceptor sites in SLP65 (Oellerich et al, 2009) and
the fact that the identiﬁed ligands execute positive as well as
negative-regulatory functions in a broad variety of BCR-
induced signal pathways such as Ca
2þ mobilization, activa-
tion of MAP kinases, regulation of apoptosis and remodelling
of the actin cytoskeleton (see Table I). Moreover, the function
of several SLP65 binding partners remains to be elucidated.
Altogether, our data provide a basis to explain how SLP65
collects and processes BCR signals as a genuine signal
integrator.
SILAC-based quantiﬁcation of ligand interactions revealed
dynamic networking of SLP65 with most of its ligands.
Noteworthy, no BCR-triggered loss of SLP65 binding partners
was observed which would have indicated signal-induced
release of SLP65 inhibitory proteins. Only a small number of
steady SLP65 ligands existed including CIN85 and CD2AP
which constitute a family of multifunctional scaffolding pro-
teins. Three atypical proline/arginine motifs of the PXXXPR
type (Kowanetz et al, 2003; Kurakin et al, 2003) in SLP65
provided highly selective docking sites for the three SH3
domains of CIN85 and CD2AP. Inactivation of the docking
sites by R-to-A exchanges and concomitant loss of CIN85/
CD2AP adaptors caused fundamental signalling deﬁcits in
DT40 and primary B cells. The mutation reduced the com-
plexity of the SLP65 interactome, blocked the BCR-proximal
substrate interaction with activated Syk and abrogated SLP65
membrane translocation that altogether abolished Ca
2þ and
NF-kB responses. In conclusion, the ability of SLP65 to form a
steady complex with CIN85/CD2AP adaptors is a critical
determinant for the functionality of the BCR transducer
complex. Microscopic imaging directly supported this result
but also suggested that CIN85 is closer associated with BCR
microclusters than CD2AP. In fact, intracellular navigation
and BCR colocalization of SLP65 were identical to that of
CIN85 but signiﬁcantly different to the trafﬁcking properties
of CD2AP. It is, therefore, likely that the BCR transducer
module utilizes predominantly CIN85 rather than CD2AP for
linking Syk activation to SLP65 phosphorylation. This model
is supported further by our gene targeting and RNA inter-
ference experiments. They also revealed that functional re-
dundancy is nonetheless possible as occupancy of the
proline/arginine motifs by CIN85 can serve at least two
functions. Docking of the N-terminal SH3 domains confers
a conformation to SLP65 that is accessible for Syk, while
the C-terminal part of CIN85 provides a subcellular targeting
signal. Depending on protein availability, the former function
might be partially substituted by SH3 domains of alterna-
tive binding partners such as Grb2 to allow for residual
Ca
2þ mobilization in our CIN85/CD2AP-compromised cells.
However, in the presence of CIN85 and CD2AP, Grb2 is
dispensable for SLP65 phosphorylation (Stork et al, 2004,
2007). Direct evidence for the potent signalling and targeting
function of the CIN85 binding sites is provided by the ability
of the T-cell adaptor SLP76 to respond to BCR activation
when equipped with the PXXXPR motifs.
CIN85 may utilize several mechanisms for subcellular
targeting of SLP65. Direct association of CIN85 to phospha-
tidic acid (Zhang et al, 2009) in concert with the membrane
binding and bending activities of known CIN85 binding
partners (Havrylov et al, 2010) could link SLP65 to signal-
ling-competent membrane microdomains. Likewise, the Cbl
family of E3 ubiquitin ligases may provide a targeting func-
tion by simultaneous binding to CIN85 and BCR-associated
Syk. In support of this possibility ablation of both Cbl and
Cbl-b expression in B cells almost abrogated SLP65 tyrosine
phosphorylation (Kitaura et al, 2007). Finally, precise sub-
cellular targeting of the CIN85/SLP65 transducer module may
also involve complex regulatory circuits of cytoskeleton
reorganization. This is suggested by the large number of
cytoskeleton regulators associated with CIN85/CD2AP
(Dikic, 2002; Havrylov et al, 2010) as well as SLP65
(see Table I) and the more recently reported impact of
actin-deﬁned networks on early BCR signalling (Treanor
et al, 2010). Additional interactions of SLP65 to Iga (Engels
et al, 2001) or accessory transmembrane proteins might
stabilize the complex. In summary, our interactome analysis
demonstrated that SLP65 acts as core structural organizer for
early and late BCR signalling responses and identiﬁed the
familyof CIN85/CD2APadaptors as missing link forsubcellular
targeting of a preformed BCR transducer complex.
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Cells, antibodies and reagents
Wild-type and SLP65-deﬁcient DT40 B cells were cultured,
stimulated and lysed as described (Oellerich et al, 2009). Ramos
B cells were activated with 8mg/ml of F(ab0)2-anti-human IgM at
371C. Human SLP65, SLP65–GFP fusion proteins and PLC-g2 were
immunoprecipitated from lysates of 2 to 3 10
7 B cells with
antibodies recognizing SLP65 (Cell Signaling Technology/BD
Biosciences), GFP (Roche) or PLC-g2 (Santa Cruz) coupled to
protein A/G sepharose (Pierce). Immunoprecipitations with J558L
cells were performed using anti-CD2AP (Santa Cruz) or rabbit
polyclonal anti-SLP65 (anti-KARLA; Wienands et al, 1998) anti-
bodies. The stimulated chicken IgM-BCR was immunoprecipitated
from the cell surface of 3 10
7 DT40 B cells by incubation of the
cells with 2mg/ml mouse anti-chicken IgM (M4, Bethyl) for various
time points at 371C and subjecting the cleared cellular lysates for 1h
to incubation with goat anti-mouse antibodies (Southern Biotech)
immobilized Protein A/G sepharose. To precipitate the resting BCR
incubations were performed on ice. Antibodies for immunoblot
analyses were used according to manufacturer’s instructions and
recognized SLP65, CD2AP, Grb-2, Sek1, Syk, phosphorylated Syk
and Lyn (all Cell Signaling Technologies/BD Biosciences), CapZ and
Dok-3 (Santa Cruz), CIN85 (Sigma), GFP (Roche) and GST
(Molecular Probes), chicken IgM (Bethyl) and phosphotyrosine
(4G10, Biomol). GST–CD2AP(SH3)3 fusion proteins were expressed
in BL21(DE3) bacteria upon induction with 0.1mM IPTG for 3h and
immobilized on Glutathione-SepharoseTM 4FastFlow (GE Health-
care). Primary splenic murine B cells were isolated using B-cell
isolation kit (Miltenyi Biotech).
Vectors, transfections and retroviral transductions
The cDNAs encoding human, murine or chicken SLP65 or human
SLP76 tagged on their C- or N-terminus with either EGFP or citrine
were ligated into pCRII-Topo. These plasmids were used to generate
triple R-to-A mutants of SLP65 (R49, 248 and 313A), or the SLP76*
variant accommodating the CIN85 binding sites (K85P, L334P,
M337R and N404R) by site-directed mutagenesis (Quikchange).
Resulting cDNA fragments were inserted into the pMSCV vector (BD
Biosciences, USA) for retroviral transduction of SLP65-deﬁcient
DT40 and primary B cells as described (Engels et al, 2009). The
cDNAs encoding N-terminally One Strep-tagged forms of chicken or
human SLP65 and its triple R-to-A variant were ligated into pAbes-
puro and transfected as described (Oellerich et al, 2009). From
each transfection, three independent clones that expressed SLP65
proteins to similar amounts than wild-type DT40 cells were pooled
and used for further experiments. Deletion variants of human
CD2AP and human CIN85 were generated by PCR yielding cDNAs
coding for CD2APDSH3 (amino acids 330–639) or CIN85DSH3
(amino acids 329–665). N-terminally citrine-tagged cDNAs were
ligated into the pMSCV vector for retroviral transduction. PCR
products encoding the three SH3 domains of CD2AP (amino acids
1–330) or CIN85 (amino acids 1–328) were ligated into pGEX-4T-1
(Amersham Biosciences), and the corresponding GST fusion pro-
teins were produced in BL21 bacteria upon induction with 0.1mM
IPTG. When used for in vitro binding studies GST–CIN85(SH3)3
fusion proteins were mixed with full-length SLP65 puriﬁed through
its N-terminal histidine (HIS) tag. BCR-induced Ca
2þ mobilization
was monitored on an LSR II cytometer (Becton Dickinson) as
described (Engels et al, 2009). Targeted disruption of cd2ap alleles
in DT40 B cells was achieved with vectors that introduced a
stop codon 30 of the third codon of exon 3 and replaced the rest
of exon 3 with either blasticidin or histidinol (HisD) resistance
cassettes. Primer sequences for ampliﬁcation of genomic fragments
50 and 30 of exon 3 (2.55 and 2.5kb, respectively) are available
on request. Following electroporation of targeting constructs, cells
were selected using 0.5mg/ml HisD and 30mg/ml blasticidin.
Retroviral vectors for interference with CIN85 expression in chicken
B cells encompassed an shRNA template oligonucleotide in which
the target CIN85 sense and antisense sequence was ﬂanked by
miR-30 miRNA sequences. Additionally, an miR-30 loop sequence
was inserted between the sense and antisense sequence. CIN85
shRNA or the control oligonucleotide (exact sequences are avail-
able on request) was ligated 50 of the IRES-GFP cassette in the
MSCV-LMP retroviral vector (Open Biosystems). Transductants
were selected with 1mg/ml puromycin.
Afﬁnity puriﬁcation of SLP65 signalosomes from
SILAC-labelled cells
Metabolic labelling via SILAC was performed as described
(Oellerich et al, 2009). For determination of the SLP65 interactome,
DT40 B cells expressing One Strep-tagged SLP65 were cultured
in heavy SILAC medium containing
13C6,
15N2-Lys (Lysþ8) and
13C6,
15N4-Arg (Argþ10), whereas cells expressing non-tagged
SLP65 were cultured in light SILAC medium containing
12C6,
14N2-
Lys and (Lysþ0)
12C6,
14N4-Arg (Argþ0). For afﬁnity puriﬁcation
of SLP65 signalosomes, 2 10
8 cells expressing tagged or non-
tagged SLP65 and labelled in heavy (Lysþ8/Argþ10) or light
(Lysþ0/Argþ0) SILAC medium were stimulated through their
BCR for indicated times and lysed as described (Oellerich et al,
2009). Protein concentrations of the lysates were determined
and normalized amounts of lysates of the differentially labelled
cells were incubated with 200mlo fStrep-Tactin Superﬂow matrix
(Iba BioTagnologies) for 1h at 41C. For each approach, 500ml
desthiobiotin buffer (Iba BioTagnologies) was used to elute puriﬁed
proteins at room temperature. Eluates were pooled in a 1:1 ratio,
concentrated in ultraﬁltration spin columns (Sartorius, Go ¨ttingen)
and proteins were separated by 1-D polyacrylamide gel electro-
phoresis. For monitoring SLP65 association kinetics, DT40 B cells
expressing One Strep-tagged SLP65 were split into three batches
and cultured in light (Lysþ0/Argþ0) or heavy (Lysþ8/Argþ10)
SILAC medium or in medium heavy (Lysþ4/Argþ6) medium
containing
2D4,
12C6,
14N2-Lys (Lysþ4) and
13C6,
14N4-Arg (Argþ6).
Lightly labelled cells were left untreated, medium heavily labelled
cells were stimulated through their BCR for 2 or 5min and heavily
labelled cells were stimulated for 10 or 20min. Following lysis and
afﬁnity puriﬁcation of SLP-65 (see above), eluates were pooled at a
1:1:1 ratio in two combinations: ﬁrst, with eluates obtained from
cells that were stimulated for 0min (light), 2min (medium heavy)
or 20min (heavy); and second, from cells stimulated for 0min
(light), 5min (medium heavy) or 10min (heavy). For analysing the
impact of the triple R-to-A mutation on the composition of the
SLP65 interactome (‘reverse proteomics’), DT40 B cells expressing
Strep-tagged wild type or the corresponding SLP65 mutant were
cultured in light (Lysþ0/Argþ0) or heavy (Lysþ8/Argþ10)
SILAC medium, respectively. SILAC-based mass spectrometric iden-
tiﬁcation and relative quantiﬁcation of all PXXXPR ligands were
performed using biotinylated peptides encompassing the central
proline/arginine motif of SLP65 as wild-type (KSPPPAAPSPLPR
AGKKPT) or binding-inactive version (KSPPPAAPSALPAAGKKPT)
for afﬁnity puriﬁcation experiments, with DT40 B cells that were
metabolically labelled in heavy or light SILAC medium, respectively.
Mass spectrometry analysis, database searching and
MaxQuant-based protein quantiﬁcation
Proteins were separated by one-dimensional SDS–PAGE (4–12%
NuPAGE Bis-Tris Gel, Invitrogen) and the entire lane of the
Coomassie blue-stained gel was cut into 23 slices. All slices were
reduced with 10mM DTT for 55min at 561C, alkylated with 55mM
IAA for 20min at 261C and digested with modiﬁed trypsin
(Promega) overnight at 371C. Tryptic peptides were injected into a
C18 precolumn (1.5cm, 360mm o.d., 150mm i.d., Reprosil-Pur
120A ˚,5mm, C18-AQ, Dr Maisch GmbH) at a ﬂow rate of 10ml/min.
Bound peptides were eluted and separated on a C18 capillary
column (15cm, 360mm o.d., 75mm i.d., Reprosil-Pur 120A ˚,5 mm,
C18-AQ, Dr Maisch GmbH) at a ﬂow rate of 300nl/min, with a
gradient from 7.5 to 37.5% ACN in 0.1% formic acid for 60min
using an Agilent 1100 nano-ﬂow LC system (Agilent Technologies)
coupled to an LTQ-Orbitrap XL hybrid mass spectrometer (Thermo
Electron). MS conditions were as followed: spray voltage, 1.8kV;
heated capillary temperature, 1501C; normalized collision-induced
dissociation (CID) collision energy 37.5% for MS/MS in LTQ. An
activation q¼0.25 and activation time of 30ms were used. The
mass spectrometer was operated in the data-dependent mode to
automatically switch between MS and MS/MS acquisition. Survey
MS spectra were acquired in the Orbitrap (m/z 350–1600) with the
resolution set to 30000 at m/z 400 and automatic gain control target
at 5 10
5. The ﬁve most intense ions were sequentially isolated for
CID MS/MS fragmentation and detection in the linear ion trap. Ions
with single and unrecognized charge states were excluded. Raw
data were analysed with MaxQuant software (Version 1.0.12.31) in
combination with Mascot search engine for peptide and protein iden-
tiﬁcations (Version 2.2.04, Matrix Science). IPI Chicken (Version 3.47)
was used as Gallus gallus sequence database. MS/MS peak lists were
The BCR transducer module
T Oellerich et al
The EMBO Journal VOL 30 | NO 17 | 2011 &2011 European Molecular Biology Organization 3632ﬁltered to contain at most six peaks per 100Da interval and searched
against Mascot server. The MS mass tolerance was set to 7p.p.m.
and MS/MS mass tolerance was set to 0.8Da. Up to three missed
cleavages of trypsin were allowed. Oxidized methionine and cysteine
carbamido-methylation were searched as variable modiﬁcations.
The modiﬁcations corresponding to arginine and lysine labelled
with heavy stable isotopes were handled as ﬁxed modiﬁcations in
the Mascot search, if applicable, after identiﬁcation of SILAC pairs
by MaxQuant. The false positive rate was set to 1% at the peptide
level, the false discovery rate was set to 1% at the protein level and
the minimum required peptide length was set to six amino acids.
Confocal laser scanning and TIRF microscopy
B cells suspended in Krebs Ringer solution composed of 10mM
HEPES (pH 7.0), 140mM NaCl, 4mM KCl, 1mM MgCl2, 1mM CaCl2
and 10mM glucose at a concentration of 10
6 cells/ml were seeded
onto Lab-TekTM chambered coverglasses, incubated at 371C for
20min and stimulated with 2mg/ml of prewarmed M4 antibodies or
10 mg/ml of anti-mouse IgM antibodies. Cells were examined on a
Leica TCS SP2 confocal laser scanning microscope. Citrine was
excited at 514nm and emission was recorded at 530–580nm. TIRF
microscopy was performed as described (Fleire et al, 2006; Depoil
et al, 2008; Weber et al, 2008).
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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